Practice Point 2.1.1: Dietary sodium restriction is usually not appropriate for patients with sodium-wasting nephropathy. Practice Point 2.1.2: The Dietary Approaches to Stop Hy- pertension (DASH)-type diet or use of salt substitutes that are rich in potassium may not be appropriate for patients with advanced CKD or those with hyporeninemic hypo- aldosteronism or other causes of impaired potassium excretion because of the potential for hyperkalemia. (For Rationale of above practice points, please see text of 2.2 Physical activity Recommendation 2.2.1: We suggest that patients with high BP and CKD be advised to undertake moderate-intensity physical activity for a cumula- tive duration of at least 150 minutes per week, or to a level compatible with their cardiovascular and physical tolerance (2C). This recommendation places a relatively higher value on evi- dence suggesting that physical activity lowers BP, improves quality of life, and improves CV health in CKD patients. The recommendation places lower value on the time investment required for physical activity and the potential for physical ac- tivity to cause adverse events in CKD patients. The recom- mendation is weak according to GRADE because of the low quality of evidence supporting the bene ts of physical activity, speci cally in hypertensive CKD populations. Key information Balance of bene ts and harms. The recommendation is driven by low-quality evidence demonstrating that physical activity may decrease BP and body weight and improve quality of life in CKD patients. The recommendation was also supported by the larger body of evidence in the general population, demonstrating the BP-lowering and other health bene ts of regular physical activity. The Work Group recognizes a higher prevalence of comorbidity and frailty in CKD compared to the general population and is uncertain about whether regular physical activity increases or decreases adverse events. 